Full text
PDFPage 588
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baglin A., Lasserre N., Prinseau J., Lebas M. Rhabdomyolyse sous traitement par le ciprofibrate au cours d'un syndrome néphrotique. Therapie. 1987 Mar-Apr;42(2):247–248. [PubMed] [Google Scholar]
- Bourrier P., Subra J. F., Chennebault J. M., Spiesser R., Laine P. Myopathie toxique due aux hypolipémiants. Therapie. 1990 Jul-Aug;45(4):360–360. [PubMed] [Google Scholar]
- Harlé J. R., Toussirot E., Disdier P., Drancourt M., Weiller P. J. L'hypothyroïdie potentialise-t-elle la toxicité musculaire des fibrates? Rev Med Interne. 1990 Jul-Aug;11(4):336–336. doi: 10.1016/s0248-8663(05)80871-9. [DOI] [PubMed] [Google Scholar]
- Litin S. C., Anderson C. F. Nicotinic acid-associated myopathy: a report of three cases. Am J Med. 1989 Apr;86(4):481–483. doi: 10.1016/0002-9343(89)90352-5. [DOI] [PubMed] [Google Scholar]
- Norman D. J., Illingworth D. R., Munson J., Hosenpud J. Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. N Engl J Med. 1988 Jan 7;318(1):46–47. doi: 10.1056/NEJM198801073180110. [DOI] [PubMed] [Google Scholar]
- O'Kane M. J., Neely R. D., Trimble E. R., Nicholls D. P. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem. 1991 Sep;28(Pt 5):509–511. doi: 10.1177/000456329102800515. [DOI] [PubMed] [Google Scholar]
- Pierides A. M., Alvarez-Ude F., Kerr D. N. Clofibrate-induced muscle damage in patients with chronic renal failure. Lancet. 1975 Dec 27;2(7948):1279–1282. doi: 10.1016/s0140-6736(75)90613-3. [DOI] [PubMed] [Google Scholar]
- White G. H., Walmsley R. N. Plasma enzyme activities in primary hypothyroidism. Clin Chem. 1984 Feb;30(2):323–325. [PubMed] [Google Scholar]